Society5 months ago
Repurposed antidepressant shows promise as cost-effective treatment for breast cancer
The research, led by Dr. Asis Bala, reveals that Selegiline, a monoamine oxidase (MAO) inhibitor, could be repurposed as an anticancer therapeutic.
